Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
EBT-101 by Excision BioTherapeutics for Human Immunodeficiency Virus (HIV) Infections (AIDS): Likelihood of Approval
EBT-101 is under clinical development by Excision BioTherapeutics and currently in Phase II for Human Immunodeficiency Virus (HIV) Infections (AIDS)....